| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |